15:21 , Mar 21, 2017 |  BC Innovations  |  Distillery Therapeutics

Autoimmune disease; gastrointestinal

INDICATION: Ulcerative colitis; colitis Patient samples and mouse studies suggest CD126 inhibitors or the...
08:00 , Dec 8, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Various

Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Colitis; colorectal cancer NLR family pyrin domain containing 12 (NLRP12; NALP12) Mouse studies suggest increasing NLRP12 signaling could help prevent colitis and colitis-associated tumorigenesis. Nlrp12-deficient...